VCAM1 and myeloid sarcoma: As for endothelial cells, our previous study revealed direct BBB‐modulating effects which included the enhancement of the barrier properties of the BBB by upregulation of claudin‐5 expression and inhibition of the increase in VCAM‐1 levels in BMECs induced by MS sera (Nishihara et al., 2015).